+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID04707872

Trifecta-Heart Study Comparing Donor-Derived Cell-Free DNA Blood Test With Molecular Microscope Gene Expression and HLA Antibody Testing for Heart Transplant Rejection

Led by University of Alberta · Updated on 2026-10-06

300

Participants Needed

12

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to understand the relationship between donor-derived cell-free DNA DD-cfDNA levels and HLA antibodies in blood samples from heart transplant recipients. It compares these blood test results with the Molecular Microscope Diagnostic System MMDx, a new diagnostic method that uses gene expression microarrays to assess heart transplant rejection and injury. The study focuses on improving the accuracy of rejection assessment beyond the current standard biopsy method, which has limitations due to variability in pathologist interpretations. Participants include heart transplant patients undergoing biopsies either for clinical reasons or as part of routine protocol monitoring. The study collects and compares data from 300 biopsies and 600 blood samples, using the Prospera test to measure DD-cfDNA levels and the MMDx system to analyze biopsy gene expression profiles. It also includes centralized testing of HLA antibodies in blood to assess donor-specific antibody status. Participants will be monitored through their standard care biopsies and blood sample collections. Researchers will evaluate the calibration of the Prospera test against MMDx findings for T cell-mediated rejection, antibody-mediated rejection, and heart injury over 18 months. Outcomes include reporting calibrated test results and assessing whether the Prospera blood test could potentially replace biopsy tests for rejection and follow-up. The study is ongoing until July 2028, with safety and diagnostic accuracy as key assessments.

CONDITIONS

Brief Title

Trifecta-Heart cfDNA-MMDx Study

Research Team

K

Konrad Famulski, PhD

R

Robert Polakowski, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here